These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6457486)

  • 21. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
    Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
    J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
    Guy K; Van Heyningen V; Dewar E; Steel CM
    Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-promoting compound (TPA) enhances interferon production in chronic lymphatic leukaemia cells.
    Adolf GR; Swetly P; Ludwig H
    Br J Haematol; 1981 Jun; 48(2):343-5. PubMed ID: 6165376
    [No Abstract]   [Full Text] [Related]  

  • 24. Membrane lipid dynamics in human promyelocytic leukemia cells sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate induction of differentiation.
    Fisher PB; Schachter D; Abbott RE; Callaham MF; Huberman E
    Cancer Res; 1984 Dec; 44(12 Pt 1):5550-4. PubMed ID: 6594192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester.
    Todd RF; Griffin JD; Ritz J; Nadler LM; Abrams T; Schlossman SF
    Leuk Res; 1981; 5(6):491-5. PubMed ID: 6948980
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of differentiation in a case of common acute lymphoblastic leukemia.
    Cossman J; Neckers LM; Arnold A; Korsmeyer SJ
    N Engl J Med; 1982 Nov; 307(20):1251-4. PubMed ID: 6982414
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differentiation of human normal and leukemic bone marrow and blood cells in tissue culture upon exposure to a tumor promotor].
    Svet-Moldavskiĭ GIa; Khollend JF; Svet-Moldavskiĭ IA; Clarkson BD
    Dokl Akad Nauk SSSR; 1979; 249(3):720-2. PubMed ID: 294343
    [No Abstract]   [Full Text] [Related]  

  • 29. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
    Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
    Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of DNA synthesis in calcium-deprived T51B liver cells by the tumor promoters phenobarbital, saccharin, and 12-O-tetradecanoylphorbol-13-acetate.
    Boynton AL; Whitfield JF
    Cancer Res; 1980 Dec; 40(12):4541-5. PubMed ID: 7438088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell differentiation and cell cycle effects on human promyelocytic leukemia cells induced by 12-O-tetradecanoylphorbol-13-acetate.
    Yun K; Sugihara H
    Lab Invest; 1986 Mar; 54(3):336-44. PubMed ID: 3456469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of human leukemias in response to 12-0-tetradecanoylphorbol-13-acetate in vitro.
    Pegoraro L; Abrahm J; Cooper RA; Levis A; Lange B; Meo P; Rovera G
    Blood; 1980 May; 55(5):859-62. PubMed ID: 6928789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester.
    Ralph P; Williams N; Moore MA; Litcofsky PB
    Cell Immunol; 1982 Aug; 71(2):215-23. PubMed ID: 6754099
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction by tumor-promoting phorbol diester of colony-stimulating activity in human myeloid leukemia cells transformed to macrophage-mimicking cells.
    Svet-Moldavskaya IA; Arlin Z; Svet-Moldavsky GJ; Clarkson BD; Koziner B; Mendelsohn N; Zinzar SN; Holland JF
    Cancer Res; 1981 Nov; 41(11 Pt 1):4335-40. PubMed ID: 6975651
    [No Abstract]   [Full Text] [Related]  

  • 35. How can altered differentiation induced by 12-O-tetradecanoylphorbol-13-acetate be related to tumor promotion?
    Schwab M
    Carcinog Compr Surv; 1982; 7():417-26. PubMed ID: 6802492
    [No Abstract]   [Full Text] [Related]  

  • 36. Inability of HL-60 cells induced by phorbol myristate acetate to produce macrophage-associated glycosaminoglycans.
    Luikart SD
    Exp Hematol; 1986 Aug; 14(7):672-5. PubMed ID: 3460812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of plasminogen activator and prostaglandin biosynthesis in HeLa cells by 12-O-tetradecanoylphorbol-13-acetate.
    Crutchley DJ; Conanan LB; Maynard JR
    Cancer Res; 1980 Mar; 40(3):849-52. PubMed ID: 7193516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposing effects of 12-O-tetradecanoylphorbol 13-acetate on human myeloid and lymphoid cell proliferation.
    Aye MT; Dunne JV
    J Cell Physiol; 1983 Feb; 114(2):209-14. PubMed ID: 6600458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced arachidonic acid lipoxygenation by K562 cells stimulated with 12-O-tetradecanoylphorbol-13-acetate.
    Valone FH; Obrist R; Tarlin N; Bast RC
    Cancer Res; 1983 Jan; 43(1):197-201. PubMed ID: 6401164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate.
    Nakaki T; Mita S; Yamamoto S; Nakadate T; Kato R
    Cancer Res; 1984 May; 44(5):1908-12. PubMed ID: 6324991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.